MCKESSON ORASOL GEL- benzocaine 20% gel 
McKesson Medical-Surgical

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

McKesson Orasol Gel

Drug Facts

Active ingredient

Benzocaine 20% (w/w)

Purpose

Oral anesthetic

Uses

For the temporary relief of minor pain and sore mouth associated with toothache, minor dental procedures and irritations from dentures or orthodontic appliances.

Warnings

For oral use only.

Do not exceed recommended dosage.

Methemoglobinemia warning:

Use of this product may cause methemoglobinemia, a serious condition that must be treated promptly because it reduces the amount of oxygen carried in the blood. This can occur even if you have used this product before.

Stop use and seek medical attention if you or a child in your care develops:

Allergy alert:

Do not use this product if you have a history of allergy to local anesthetics, such as procaine, butacaine, benzocaine, or other “caine” anesthetics. If a skin reaction occurs, stop use and seek medical help right away.

Do not use

Stop use and ask a dentist or doctor if

When using this product

Keep out of reach of children.

If accidentally swallowed get medical help or contact a Poison Control Center right away.

Directions

Adults and children (2 years and older):

Dry affected area and apply medication undiluted. Use up to 4 times daily, but not more than every two hours, or as directed by a dentist or doctor.

Children under 2 years:

Do not use

Other information

Inactive ingredients

PEG 400, PEG 3350, peppermint oil, sodium saccharin, sorbic acid

Questions or comments? Call 1-800-777-4908

NDC 68599-8247-4

McKesson

Orasol Gel

Individual Packets

Benzocaine 20% | Oral Anesthetic

Temporary relief of minor pain and sore mouth.

NET WT 0.75 g

75 Packs Per Box

Do Not Reuse

MFR # 82474

McKesson

MCKESSON ORASOL GEL 
benzocaine 20% gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68599-8247
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE200 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)  
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
PEPPERMINT OIL (UNII: AV092KU4JH)  
SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
SORBIC ACID (UNII: X045WJ989B)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68599-8247-475 in 1 BOX10/04/2021
10.75 g in 1 PACKET; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35610/04/2021
Labeler - McKesson Medical-Surgical (023904428)
Registrant - Unifirst First Aid Corporation (832947092)

Revised: 10/2022
Document Id: ebdd753c-7c87-4956-e053-2995a90abc35
Set id: cc8724f4-c482-5e7d-e053-2a95a90a608f
Version: 2
Effective Time: 20221025
 
McKesson Medical-Surgical